Saeed Banaeian Far | Bioinformatics | Innovative Research Award

Published on by Research Data Analysis

Innovative Research Award

Saeed Banaeian Far – Blockchain and Metaverse research lab

Saeed Banaeian Far
Affiliation Blockchain and Metaverse research lab
Country Iran
Scopus ID 57203846778
Documents 37
Citations 736
h-index 11
Subject Area Bioinformatics
Event International Research Data Analysis Excellence & Awards
ORCID 0000-0003-2520-8492

Saeed Banaeian Far is a researcher affiliated with the Blockchain and Metaverse research lab in Iran, with a stated subject area of Bioinformatics. Available researcher-profile information records 37 documents, 736 citations, and an h-index of 11. These indicators provide a quantitative context for considering research activity and scholarly visibility in relation to the Innovative Research Award. [1]

Abstract

Saeed Banaeian Far is presented in the context of an Innovative Research Award for research associated with Bioinformatics and data-oriented scientific inquiry. The supplied profile indicates 37 documents, 736 citations, and an h-index of 11. These indicators offer a concise basis for documenting scholarly activity, research visibility, and potential recognition within an academic awards framework. [2]

Keywords

  • Bioinformatics
  • Research Data Analysis
  • Computational Research
  • Scholarly Impact
  • Research Innovation
  • Digital Research

Introduction

Bioinformatics integrates computational methods with biological research, enabling researchers to organize, analyze, and interpret complex scientific datasets. Within this interdisciplinary environment, data-driven approaches support reproducible investigation and evidence-based discovery. Saeed Banaeian Far’s supplied academic profile places his research within Bioinformatics and provides measurable indicators of scholarly activity for award consideration. [3]

Research Profile

Saeed Banaeian Far is affiliated with the Blockchain and Metaverse research lab in Iran and is identified with the subject area of Bioinformatics. The supplied Scopus information lists 37 documents, 736 citations, and an h-index of 11. His ORCID record provides a persistent researcher identifier that can assist with scholarly identity management and attribution. [2]

Research Contributions

The available information indicates sustained scholarly activity through a documented body of research publications and associated citation records. In Bioinformatics, contributions may involve computational analysis, structured data interpretation, digital methods, and interdisciplinary research. Specific contributions should be assessed through individual publications, methodologies, datasets, and documented findings rather than citation indicators alone. [3]

Publications

The supplied profile reports 37 scholarly documents associated with the researcher. A complete publication assessment would consider article topics, journals, authorship roles, methodological originality, datasets, citations, and reproducibility. Because individual publication titles and DOI records were not supplied, this page does not attribute specific findings or publications beyond the documented bibliometric information. [1]

Research Impact

The supplied bibliometric indicators report 736 citations and an h-index of 11, providing measurable evidence of scholarly visibility within indexed research literature. Such indicators can help contextualize research influence, although they do not independently establish scientific quality or societal impact. A balanced assessment should combine quantitative metrics with publication quality, reproducibility, and substantive research outcomes. [2]

Award Suitability

The Innovative Research Award can be considered in relation to documented research activity, interdisciplinary relevance, scholarly outputs, and measurable academic impact. The supplied profile demonstrates a defined Bioinformatics subject area, 37 documents, 736 citations, and an h-index of 11. Final award suitability should additionally be determined through the event’s official evaluation criteria and submitted evidence. [1]

Conclusion

Saeed Banaeian Far’s supplied profile presents an academic record associated with Bioinformatics and research data-oriented scholarship. The reported publication and citation indicators provide a useful quantitative overview of research activity and visibility. Further evaluation of individual studies, methodological contributions, collaboration, and reproducibility would provide a more comprehensive basis for assessing innovation and award-level research achievement. [2]

References

  1. Emp-secure data storage through biohybrid and neuromorphic paradigms.
    https://link.springer.com/article/10.1007/s42452-026-08627-9
  2. Toward Metaverse of everything: Opportunities, challenges, and future directions of the next generation of visual/virtual communications.
    https://www.researchgate.net/publication/371277626_Toward_Metaverse_of_everything_Opportunities_challenges_and_future_directions_of_the_next_generation_of_visualvirtual_communications
  3. Rebellious AI can be controlled by submissive AI: an overview of background, identifying major problems, and taxonomizing possible solutions.
    https://link.springer.com/article/10.1007/s10462-026-11567-w

Refiloe Malesa | Bioinformatics | Best Researcher Award

Published on by Research Data Analysis

Best Researcher Award

Refiloe Malesa
University of South Africa
Refiloe Malesa
Affiliation University of South Africa
Country South Africa
Scopus ID 57215971261
Documents 5
Citations 29
h-index 3
Subject Area Bioinformatics
Event International Research Data Analysis Excellence & Awards
ORCID 0000-0002-5205-695X

Refiloe Malesa is a South African researcher whose scholarly activities contribute to the fields of bioinformatics, microbial genomics, veterinary diagnostics, and infectious disease surveillance. Her published work demonstrates a focus on pathogen characterization, genomic analysis, epidemiological monitoring, and laboratory assay optimization. Through studies involving Escherichia coli, African swine fever virus, peste des petits ruminants virus, and foot-and-mouth disease virus, she has contributed to scientific understanding of animal health and food safety challenges. These contributions provide a foundation for evaluating her suitability for academic recognition under the Best Researcher Award category.[1]

Abstract

This article presents an academic overview of Refiloe Malesa and her research contributions in bioinformatics and pathogen genomics. Her scholarly output includes investigations into bacterial virulence mechanisms, genomic characterization of pathogens, diagnostic assay optimization, and molecular epidemiology. The body of work demonstrates interdisciplinary engagement across computational biology, veterinary science, and public health research, supporting scientific knowledge relevant to disease control and food security.[2]

Keywords

Bioinformatics, Genomics, Veterinary Diagnostics, Pathogen Surveillance, Escherichia coli, Animal Health, Disease Epidemiology, Molecular Biology.

Introduction

Contemporary bioinformatics research increasingly supports evidence-based approaches to disease monitoring and pathogen characterization. Refiloe Malesa has participated in studies addressing infectious diseases affecting livestock and food-production systems. Her research combines laboratory methods with genomic analysis to improve understanding of pathogen diversity, transmission pathways, and diagnostic effectiveness.[3]

Research Profile

According to available scholarly metrics, Refiloe Malesa has produced multiple indexed publications with measurable citation activity and an established h-index. Her research interests encompass microbial genomics, pathogen evolution, veterinary virology, diagnostic assay development, and genomic epidemiology. The scope of her work reflects practical relevance for agriculture, veterinary medicine, and public health sectors.[1]

Research Contributions

  • Investigated Type III Secretion Systems and effector proteins in enteropathogenic Escherichia coli strains using genome-based bioinformatics approaches.
  • Characterized generic Escherichia coli isolates from food-producing animals and products of animal origin in South Africa.
  • Contributed to optimization of diagnostic ELISA methodologies for foot-and-mouth disease surveillance.
  • Studied molecular diversity of peste des petits ruminants virus lineages affecting sheep and goats.
  • Reported genome sequences of African swine fever viruses from Southern Africa.

Publications

  1. Genome-Based In Silico Analysis of the Structural and Functional Characteristics of the Type Three Secretion System (T3SS) and Core Effector Proteins in EPEC Strains (2025).
  2. Genomic Characterisation of Generic Escherichia coli from Food-Producing Animals and Products of Animal Origin in South Africa (2024).
  3. Optimization of a Foot-and-Mouth Disease Virus SAT-Specific Competitive ELISA (2024).
  4. Peste des Petits Ruminants in Nigeria: Identification and Variations of Viral Lineages (2021).
  5. Genome Sequences of Three African Swine Fever Viruses from South Africa and Zambia (2020).

Research Impact

The research portfolio of Refiloe Malesa demonstrates contributions to understanding pathogen genomics and disease diagnostics. Her studies support scientific efforts directed toward livestock disease management, food safety monitoring, and molecular epidemiology. The integration of genomic technologies with applied veterinary research strengthens the practical relevance of her publications and their potential influence on future investigations.[4]

Award Suitability

For the International Research Data Analysis Excellence & Awards program, Refiloe Malesa demonstrates characteristics commonly associated with research excellence, including peer-reviewed publication activity, interdisciplinary collaboration, and contributions to scientifically relevant challenges. Her work in bioinformatics and infectious disease genomics reflects methodological rigor and ongoing engagement with globally significant veterinary and public health concerns.[5]

Conclusion

Refiloe Malesa has established a focused research profile within bioinformatics and pathogen genomics. Her publications address diagnostic development, genomic characterization, and disease surveillance in animal populations. Based on documented scholarly outputs and research contributions, her profile represents a noteworthy example of emerging academic achievement within the field of applied biological sciences.[6]

References

  1. Elsevier. (n.d.). Scopus author details: Refiloe Malesa, Author ID 57215971261. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57215971261
  2. Malesa, R. (2025). Genome-Based In Silico Analysis of the Structural and Functional Characteristics of the Type Three Secretion System.
    DOI: https://doi.org/10.3390/pathogens14111099
  3. Malesa, R. (2024). Genomic Characterisation of Generic Escherichia coli from Food-Producing Animals and Products of Animal Origin in South Africa.
    DOI: https://doi.org/10.3389/fbrio.2024.1432292
  4. Malesa, R. (2024). Optimization of a Foot-and-Mouth Disease Virus Southern African Territories-Specific Competitive ELISA.
    DOI: https://doi.org/10.1177/10406387231218202
  5. Malesa, R. (2021). Peste des Petits Ruminants in Nigeria: Identification and Variations of Lineage II and IV.
    DOI: https://doi.org/10.12834/VetIt.2390.14842.1
  6. Malesa, R. (2020). Genome Sequences of Three African Swine Fever Viruses of Genotypes I, III, and XXII.
    DOI: https://doi.org/10.1128/mra.01376-19

Natalia Herman-Sanchez | Bioinformatics | Young Scientist Award

Published on by Research Data Analysis

Ms. Natalia Herman-Sanchez | Bioinformatics | Young Scientist Award

University of Cordoba | Spain

PUBLICATION PROFILE

Orcid

👩‍🔬 INTRODUCTION

Natalia Hermán-Sánchez is a talented pre-doctoral researcher at the University of Córdoba, Spain. She is dedicated to advancing biomedical research, particularly in the study of liver diseases and cancer. Through her work, Hermán-Sánchez is exploring vital molecular processes, such as RNA splicing and SUMOylation, which play key roles in liver cancer development. As an FPU grant recipient, her contributions are shaping the future of scientific research in this critical area.

🎓 EARLY ACADEMIC PURSUITS

Natalia’s academic journey began with a strong foundation in biochemistry at the University of Córdoba, where she earned her Bachelor’s degree in 2020. She then pursued a Master’s degree in Translational Biomedical Research, completed in 2021, and also obtained a diploma in Bioinformatics Analysis from the University Pablo de Olavide in 2024. These accomplishments laid the groundwork for her deep dive into the molecular biology of cancer and liver diseases.

🧑‍💼 PROFESSIONAL ENDEAVORS

Since 2021, Hermán-Sánchez has been working as a pre-doctoral researcher at the University of Córdoba under the FPU grant program. Her professional focus has been centered on understanding liver diseases and hepatocellular carcinoma (HCC). She is specifically investigating the roles of RNA splicing factors and other molecular mechanisms involved in disease progression, with the aim of discovering novel biomarkers and therapeutic targets.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS

Hermán-Sánchez’s research is at the forefront of liver disease and cancer research. She has contributed significantly to studies on RNA splicing, SUMOylation, and the post-transcriptional regulation of genes in liver cancer. Her work aims to uncover new diagnostic and prognostic markers, with several impactful publications in top-tier journals like Cell Reports and Experimental & Molecular Medicine. Through this research, she is shaping our understanding of liver cancer biology and offering potential pathways for clinical interventions.

🌍 IMPACT AND INFLUENCE

Hermán-Sánchez’s research is making waves in the scientific community, particularly in the study of liver cancer. Her work has been widely cited and has influenced ongoing research in cancer biology and liver diseases. By presenting her findings at major international conferences such as the European Association for the Study of the Liver (EASL), she is contributing to the global conversation on liver cancer and molecular oncology, solidifying her place as an emerging leader in the field.

📚 ACADEMIC CITATIONS AND PUBLICATIONS

Natalia’s growing list of scientific publications reflects her significant contributions to the fields of hepatology and cancer research. Her research on RNA splicing factors in hepatocellular carcinoma has gained significant attention in the scientific community. These publications underscore her potential as a rising star in biomedical research, with a focus on advancing our understanding of cancer and chronic liver diseases.

🏅 HONORS & AWARDS

Throughout her academic journey, Hermán-Sánchez has received recognition for her work, including invitations to present at prestigious scientific events. Her research has earned her several honors and awards, highlighting her potential as a future leader in biomedical research. Her presentations at conferences have been recognized for their scientific merit, showcasing her contributions to liver cancer research.

🌟 LEGACY AND FUTURE CONTRIBUTIONS

As she continues her research, Hermán-Sánchez is poised to make lasting contributions to the field of biomedical science. Her exploration of molecular mechanisms in liver cancer holds the potential to uncover new therapeutic strategies and diagnostic tools, benefiting patients worldwide. Her continued dedication to understanding the biology of liver diseases ensures that her future work will have a profound impact on clinical practices and cancer treatment.

💬 FINAL CONCLUSION

In summary, Natalia Hermán-Sánchez is a promising and impactful researcher whose work is helping to redefine our understanding of liver cancer and disease. Through her academic achievements, professional experience, and groundbreaking research, she is paving the way for new diagnostic and therapeutic approaches that could ultimately improve patient outcomes. Hermán-Sánchez’s future contributions to biomedical research and clinical medicine are poised to leave a lasting legacy in the fight against liver diseases and cancer.

 📚 TOP NOTES PUBLICATIONS

PRPF8 increases the aggressiveness of hepatocellular carcinoma by regulating FAK/AKT pathway via fibronectin 1 splicing
    • Authors: Juan L. López-Cánovas, Natalia Hermán-Sánchez, Mercedes del Rio-Moreno, Antonio C. Fuentes-Fayos, Araceli Lara-López, Marina E. Sánchez-Frias, Víctor Amado, Rubén Ciria, Javier Briceño, Manuel de la Mata et al.
    • Journal: Experimental & Molecular Medicine
    • Year: 2023-01-06
Spliceosomal profiling identifies EIF4A3 as a novel oncogene in hepatocellular carcinoma acting through the modulation of FGFR4 splicing
    • Authors: Juan L. López‐Cánovas, Natalia Hermán‐Sánchez, Maria Trinidad Moreno‐Montilla, Mercedes del Rio‐Moreno, Emilia Alors‐Perez, Marina E. Sánchez‐Frias, Víctor Amado, Rubén Ciria, Javier Briceño, Manuel de la Mata et al.
    • Journal: Clinical and Translational Medicine
    • Year: 2022-11
Multidisciplinary Prehabilitation and Postoperative Rehabilitation for Avoiding Complications in Patients Undergoing Resection of Colon Cancer: Rationale, Design, and Methodology of the ONCOFIT Study
    • Authors: Amaro-Gahete, FJ, Javier Jurado, Andrea Cisneros, Pablo Corres, Andres Marmol-Perez, Francisco J. Osuna-Prieto, Manuel Fernández-Escabias, Estela Salcedo, Natalia Hermán-Sánchez, Manuel D. Gahete et al.
    • Journal: Nutrients
    • Year: 2022-11-03
Dysregulation of splicing variants and spliceosome components in breast cancer
    • Authors: Manuel D Gahete, Natalia Herman-Sanchez, Antonio C Fuentes-Fayos, Juan L Lopez-Canovas, Raúl M Luque
    • Journal: Endocrine-Related Cancer
    • Year: 2022-09-01
Morphofunctional and Molecular Assessment of Nutritional Status in Head and Neck Cancer Patients Undergoing Systemic Treatment: Role of Inflammasome in Clinical Nutrition
    • Authors: Soraya León-Idougourram, Jesús M. Pérez-Gómez, Concepción Muñoz Jiménez, Fernando L-López, Gregorio Manzano García, María José Molina Puertas, Natalia Herman-Sánchez, Rosario Alonso-Echague, Alfonso Calañas Continente, María Ángeles Gálvez Moreno et al.
    • Journal: Cancers
    • Year: 2022-01-19